Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

ClinicalTrials.gov ID: NCT03138655

Public ClinicalTrials.gov record NCT03138655. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 12:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Dose-Ranging Study to Determine the Pharmacokinetics, Safety and Tolerability of Vedolizumab IV in Pediatric Subjects With Ulcerative Colitis or Crohn's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate vedolizumab pharmacokinetics (PK), safety and tolerability in pediatric participants with moderately to severely active UC or CD.

Study identification

NCT ID
NCT03138655
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Takeda
Industry
Enrollment
89 participants

Conditions and interventions

Eligibility (public fields only)

Age range
2 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 8, 2017 (Actual)
Primary completion
Mar 31, 2020 (Actual)
Completion
May 26, 2020 (Actual)
Last update posted
Dec 21, 2020

2017 – 2020

United States locations

U.S. sites
27
U.S. states
18
U.S. cities
25
Facility City State ZIP Site status
Cedars-Sinai Medical Center Los Angeles California 90048 —
Children's Hospital of Orange County Orange California 92868 —
University of California San Francisco San Francisco California 94143-0135 —
Connecticut Children's Medical Center Hartford Connecticut 06106-3322 —
Nemours Children's Clinic Wilmington Delaware 19803 —
Nemours Childrens Specialty Care - Jacksonville Jacksonville Florida 32207 —
Nicklaus Children's Hospital Miami Florida 33155 —
Children's Center for Digestive Healthcare Atlanta Georgia 30342 —
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60614 —
Indiana University School of Medicine - Indianapolis Indianapolis Indiana 46202 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Boston Children's Hospital Boston Massachusetts 02115 —
Mayo Clinic - Rochester Rochester Minnesota 55905-0001 —
Washington University in St. Louis St Louis Missouri 63110 —
Northwell Health Lake Success New York 11042 —
Mount Sinai Medical Center New York New York 10029 —
Columbia University Medical Center New York New York 10031 —
The Children's Hospital at Montefiore The Bronx New York 10467 —
University Hospitals Rainbow Babies & Children's Hospital Cleveland Ohio 44106 —
The Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15224 —
Medical University of South Carolina Charleston South Carolina 29425 —
Childrens Medical Center of Dallas Dallas Texas 75235 —
Texas Children's Hospital Houston Texas 77030 —
University of Utah Salt Lake City Utah 84113 —
Children's Specialty Group - Medical Center Location Norfolk Virginia 23507 —
Seattle Children's Hospital Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 61 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03138655, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 21, 2020 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03138655 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →